Share
In funding news, congratulations to Neogene Therapeutics for nabbing a major $110 million series A ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

View in Browser »

Hi ,

We hope you enjoy this week’s digest. If you know of colleagues who might enjoy it then they can sign up here.

In this fireside chat at SynBioBeta, Alex Lorestani and Erin Kim chat about how Geltor is creating biodesigned solutions for the beauty, nutrition, food and beverage industries. "Biodesign is the future of manufacturing and the backbone of product innovation for a number of industries today," according to Alex Lorestani.

Good Meat announced the building of the world’s largest bioreactors to produce cultivated meat, with the potential to supply tens of thousands of shops and restaurants. The bioreactors can grow more than 13,000 tonnes of chicken and beef a year and will use cells taken from cell banks or eggs.

In funding news, Humble Bee raised $3.2 million to create bioplastics. The company has been studying the Australian masked bee, a type of bee that makes a nesting material for laying larvae in, which has many plastic-like properties.

Joywell Foods raised $25 million to bring sweet proteins to market. Joywell uses a microbial fermentation process to produce sweet proteins that are nearly identical to those found in exotic fruits and berries.

London-based biomaterial company, Modern Synthesis, has raised $4.1 million in seed funding to accelerate development of their proprietary microbial textile platform, which employs bacteria to grow a new class of biomaterials, and is aimed at curbing fashion industry emissions and plastic pollution.

Royal DSM NV will combine with Swiss ingredients maker Firmenich to form the largest maker of fragrances, completing its transformation from chemicals company into one more focused on consumer goods.

Zymergen announced it has entered into an agreement with Octant for the sale of a modular automation system to scale Octant’s next-generation platform to develop breakthrough medicines.

The venture capital firm SOSV and its startup development program IndieBio have teamed up with the Genome Project-write (GP-write), a global nonprofit genome engineering consortium, to launch the GP-write Startup Team, a project designed to vet, select, fund, and advise new ventures advancing the technology and science of writing genomes.

What is the true potential of biomanufacturing, how can it contribute to a bio-economy revolution and what collaborations are required to unlock its full potential at scale? Watch Megan Palmer, Trish Malarkey, Jason Kelly, Ric Fulop, Trevor Martin speaking at the WEF.

The Race Against the Clock is partnering with ValleyDAO to bring the RATC <> ValleyDAO Journal Club! In this kickoff session, we will discuss the Nature Article: Machine learning-aided engineering of hydrolases for PET depolymerization.

Finally, check out this webinar on June 21: 'Yeastern' Medicine: Brewing nightshade drugs with genetically modified yeast using whole-cell engineering

Spotlight on: SQIM

It’s no secret that animal agriculture is severely damaging our planet. While we transition our diets to sustainable proteins, we also need to reimagine our materials, especially leather. Meet SQIM, a materials company bringing plastic-free "mycelium leather" to market! By leveraging liquid and solid-state fermentation, SQIM is quickly scaling the production of EPHEA, a novel class of superior materials that can be thoroughly customized for use in the fashion industry. EPHEA can be dyed, embossed, finished, and adapted to create animal-free, high-quality products, without harming our planet. Learn more about SQIM, the ongoing scale-up of EPHEA, and their commercially available mycelium-based products for interior design, MOGU! (image: EPHEA)

Featured News

Scientists create tomatoes genetically edited to bolster vitamin D levels

The tomatoes contain as much provitamin D3 as two eggs, with UK outdoor field trials starting next month

Keep Reading »

Synthesis Capital closed its first fund with $300M, giving boost to food tech’s future

Recognition that foodtech is a solution to a few of the problems out there, and that venture capital and government are more interested in the space, is important, Yiannoulis told TechCrunch.

Keep Reading »

Download the application note to learn how Inscripta’s Onyx® Digital Genome Engineering Platform can be used for rapid strain engineering to improve heterologous protein production.

Keep Reading »

Future Meat Technologies expands executive leadership team, continues momentum towards commercialization

Veteran leaders will accelerate Future Meat's development as the company plans to build U.S. operations and bring cultivated meat products to the market.

Keep Reading »

Other News

Who's hiring?

Access The Job Board »

Like our Digest? Please feel free to share with friends, family, and co-workers!


Built With Biology, LLC
3559 Mount Diablo Boulevard #2, Lafayette, CA 94549

info@builtwithbiology.com

If you no longer wish to receive our emails, you can unsubscribe here.
Modify Your Email Preferences


Email Marketing by ActiveCampaign